Salvo Organic Industries PLC. announcements
250 Dhaka Stock Exchange announcements for Salvo Organic Industries PLC. (SALVO) since 2011: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (40).
- Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 6,00,000 shares of the company at prevailing market price (in the Public and/or Block Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 (thirty) working days pursuant to the Regulation 34(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, as well as Rule 4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.
- Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 7,00,000 shares of the company at prevailing market price (in the Public and/or Block Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 (thirty) working days pursuant to the Regulation 34(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, as well as Rule 4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.
- Buy confirmation of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has completed his buying of 440,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. (DSE) as per declaration disseminated on 11.12.2025.
- Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 4,40,000 shares of the company at prevailing market price (in the Public and/or Block Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 (thirty) working days pursuant to the Regulation 34(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, as well as Rule 4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.
- Buy confirmation of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has completed his buying of total 900,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. (DSE) as per declarations disseminated on 30.11.2025 and 08.12.2025.
- Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 4,50,000 shares of the company at prevailing market price (in the Public and/or Block Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 (thirty) working days pursuant to the Regulation 34(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, as well as Rule 4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.
- SALVOCHEM: Trading Code Change of the Company
Dhaka Stock Exchange PLC. (DSE) has approved the proposed trading code change of the Company. Accordingly, the trading code of the Company will be 'SALVO' instead of 'SALVOCHEM' with effect from December 03, 2025. Other information (except trading code) will remain unchanged.
- SALVOCHEM: Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 4,50,000 shares of the company at prevailing market price (in the Public and/or Block Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 (thirty) working days pursuant to Regulation 34(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, as well as Rule 4 of the BSEC (Ullekhzogyo Sonkhyok Share Orjon, Odhigrohon o Kortritto Grohon) Bidhimala, 2018.
- SALVOCHEM: Buy confirmation of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has completed his buying of 4,40,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. (DSE) as per declaration disseminated on 13.11.2025.
- SALVOCHEM: Buy confirmation of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has completed his buying of 4,40,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. (DSE) as per declaration disseminated on 20.11.2025.
Posted under the former code SALVOCHEM. - SALVOCHEM: Buy confirmation of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has completed his buying of 3,33,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. (DSE) as per declaration disseminated on 17.11.2025.
- SALVOCHEM: Name Change of the Company
Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Salvo Organic Industries PLC.' instead of 'Salvo Chemical Industry Limited' with effect from November 24, 2025. Other information (except name) will remain unchanged.
- SALVOCHEM: Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 4,40,000 shares of the company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.
- SALVOCHEM: Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 3,33,000 shares of the company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.
- SALVOCHEM: Buy confirmation of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has completed his buying of 3,33,000 shares and 3,50,000 shares of the company at prevailing market price through Dhaka Stock PLC. (DSE) as per declaration disseminated on 05.11.2025 and 10.11.2025 respectively.
- SALVOCHEM: Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 4,40,000 shares of the company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.
- SALVOCHEM: Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 3,50,000 shares of the company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.
- SALVOCHEM: Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.14 for July-September 2025 as against Tk. 0.13 for July-September 2024. NOCFPS was Tk. 1.55 for July-September 2025 as against Tk. 0.85 for July-September 2024. NAV per share was Tk. 16.70 as on September 30, 2025 and Tk. 16.57 as on June 30, 2025. (cont.)
Posted under the former code SALVOCHEM. - SALVOCHEM: Q1 Financials
(Cont. News of SALVOCHEM): Reasons for deviation in EPS and NOCFPS: Earnings per share (EPS) has been increased compared to the same period of previous year due to increase of sales volume. During this period NOCFPS increased due to increase of sales and collection from customers. As a result, net cash generated from operating activities has been increased compare to same period of previous year. (end)
The first part of this announcement is missing from the archive. - SALVOCHEM: Buy Declaration of Managing Director of the Company
Mr. Md. Salam Obaidul Karim, Managing Director of the company, has expressed his intention to buy 3,33,000 shares of the company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.
- SALVOCHEM: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 05, 2025 at 3:00 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
- SALVOCHEM: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.
- SALVOCHEM: Placing Special Resolution in AGM for name change of the company
The company has informed the following: To change the name of the company to 'Salvo Organic Industries PLC' from 'Salvo Chemical Industry Limited' and to amend the related clause of the Memorandum & Articles of Association of the Company, subject to approval from the Registrar of Joint Stock Companies & Firms and regulatory authorities which will be placed before the shareholders in the 23rd Annual General Meeting as a Special Resolution.
- SALVOCHEM: Qualified Opinion and Emphasis of Matter
The auditor of the company has given the "Qualified Opinion" and "Emphasis of Matter" paragraphs in the Auditor's Report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/SalvoChemical30062025.pdf
- SALVOCHEM: Resumption after Record Date
Trading of the shares of the company will resume on 09.09.2025.
- SALVOCHEM: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 08.09.2025.
- SALVOCHEM: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 04.09.2025 to 07.09.2025 and trading of the shares will remain suspended on record date i.e., 08.09.2025.
- SALVOCHEM: Dividend Declaration
The Board of Directors has recommended 2.50% Cash Dividend for the year ended June 30, 2025. Date of AGM: 29.09.2025; Time: 10:30 AM; Venue: Hybrid System at Institution of Diploma Engineers Bangladesh, IDEB Bhaban, 160/A, Kakrail VIP Road, Dhaka-1000, Bangladesh. Record Date: 08.09.2025. The Company has also reported EPS of Tk. 0.58, NAV per share of Tk. 16.57 and NOCFPS of Tk. 5.68 for the year ended June 30, 2025 as against Tk. 1.66, Tk. 16.24 and Tk. 5.43 respectively for the year ended June 30, 2024.
- SALVOCHEM: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (19.08.2025) following its corporate declaration.
- SALVOCHEM: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on August 18, 2025 at 2:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
- SALVOCHEM: Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has assigned the company as "BBB" in the long term and "ST-3" for short term along with Stable outlook in consideration of its audited financials up to June 30, 2024 also unaudited financials up to March 31, 2025 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- SALVOCHEM: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.17 for January-March 2025 as against Tk. 0.66 for January-March 2024; EPS was Tk. 0.39 for July 2024-March 2025 as against Tk. 1.97 for July 2023-March 2024. NOCFPS was Tk. 3.68 for July 2024-March 2025 as against Tk. 3.57 for July 2023-March 2024. NAV per share was Tk. 16.34 as on March 31, 2025 and Tk. 16.24 as on June 30, 2024. (cont.)
Posted under the former code SALVOCHEM. - SALVOCHEM: Q3 Financials
(Continuation news of SALVOCHEM): EPS has been decreased compared to the same period of previous year due to increase of production cost, the price hike of material, inflation, currency devaluation, increase of manufacturing overhead that affects COGS and reducing gross margin while revenue increase by 15%. In addition, significant increase of finance expenses causes reducing overall profitability of the Company. (end)
The first part of this announcement is missing from the archive. - SALVOCHEM: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
- SALVOCHEM: Regarding raising of capital through private placement
Refer to the earlier news disseminated by DSE on 08.12.2024 regarding re-apply to BSEC for raising paid-up capital, Bangladesh Securities and Exchange Commission (BSEC) through its letter no. BSEC/CI/CPLC (Public)-1118/2024/Part-I/411 has further informed that BSEC is not in a position to accord consent for issuance of 64,00,000 ordinary shares at Tk. 16 each (cont.)
Posted under the former code SALVOCHEM. - SALVOCHEM: Regarding raising of capital through private placement
(Cont. news of SALVOCHEM): amounting to Tk. 10,24,00,000 (ten crore and twenty-four lac) to the existing sponsors & directors of the company through private placement in cash consideration, for the greater interest of general investors. (end)
The first part of this announcement is missing from the archive. - SALVOCHEM: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.09 for October-December 2024 as against Tk. 0.57 for October-December 2023; EPS was Tk. 0.22 for July-December 2024 as against Tk. 1.31 for July-December 2023. NOCFPS was Tk. 1.76 for July-December 2024 as against Tk. 1.39 for July-December 2023. NAV per share was Tk. 16.49 as on December 31, 2024 and Tk. 16.24 as on June 30, 2024. (cont.1) (Cont. News of SALVOCHEM): Reasons for deviation: Earning per share (EPS) has been decreased compared to the same period of previous year due to increase of production cost, high raw material price, inflation, currency devaluation, increase in utility rate and increase of manufacturing overhead that affects COGS and reducing gross margin while sales increase by 13%. (cont.2)
Posted under the former code SALVOCHEM. - SALVOCHEM: Q2 Financials
(Cont. News of SALVOCHEM): As well as non-operating expenses increase due to bank interest rate changes from 9% to 15.50% which affected overall profitability of the Company. Thus, the EPS during this period ended on 31 December 2024 has decreased significantly than the previous period. During this period NOCFPS increase due to increase of sales and collection from customers. As a result, net cash generated from operating activities has been increased compare to same period of previous year. (end)
The first part of this announcement is missing from the archive. - SALVOCHEM: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- SALVOCHEM: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.